Clinical trial
The Long-term Effects of the Covid-19 Infection on Cardiac Symptoms, Should We Have a Realistic Concern?
Name
IR.SUMS.MED.REC.1401.465
Description
From the registry of professor Kojuri clinic , those with Covid-19 infection were selected and was contacted and asked about the cardiovascular symptoms, 1 year after the covid infection
Trial arms
Trial start
2020-10-01
Estimated PCD
2021-05-01
Trial end
2021-05-01
Status
Completed
Treatment
covid infection
patients with covid infection which was proved with positive test
Arms:
diseased
Other names:
covid 19 infection
admission to hispital
patients with sever covid disease, who was admitted in hospital
Arms:
diseased
Size
879
Primary endpoint
dyspnea
1 year
chest pain
1 year
MACE
1 year
Eligibility criteria
Inclusion Criteria:
* COVID-19 infection confirmed by PCR or suggested by HRCT findings and having been afflicted with COVID-19 at least one year ago
Exclusion Criteria:
* COVID-19 infection, which occurred less than a year ago,
* probable history of COVID-19 not confirmed by PCR or HRCT
Protocol
{'studyType': 'OBSERVATIONAL', 'patientRegistry': True, 'targetDuration': '365 Days', 'designInfo': {'observationalModel': 'CASE_CONTROL', 'timePerspective': 'PROSPECTIVE'}, 'enrollmentInfo': {'count': 879, 'type': 'ACTUAL'}}
Updated at
2023-05-01
1 organization
1 product
4 indications
Organization
Shiraz University of Medical SciencesProduct
Admission to HospitalIndication
COVID-19Indication
DyspneaIndication
Acute Chest SyndromeIndication
Functional Cardiac Disorder